... San Antonio. The interview highlights the growing body of preclinical ... astr<60 is a webinar series created by astr partners for biotech and finance ...
News
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
- AI-Powered Deep Proteomics Enables Early, Non-Imaging Detection of Breast Cancer With ...
At the San Antonio Breast Cancer Symposium (SABCS) in San Antonio ... Bioscience's Certitude Breast test, a breakthrough, AI-powered proteomics ...
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at ...
Ralph DeFronzo, Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio. ... biotech and finance leaders seeking clear, ...
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...
- BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposium - GuruFocus
Key Takeaways: BriaCell Therapeutics (BCTX) presented promising Phase 2 and 3 trial data at the 2025 San Antonio Breast Cancer Symposium.